Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Streptococcus pyogenes Infections - Overview
Streptococcus pyogenes Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Streptococcus pyogenes Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Streptococcus pyogenes Infections - Companies Involved in Therapeutics Development
Cadila Healthcare Ltd
Crestone Inc
Olymvax Biopharmaceuticals Inc
Recce Pharmaceuticals Ltd
Wellstat Vaccines LLC
Streptococcus pyogenes Infections - Drug Profiles
(mupirocin calcium + neomycin sulfate + HT-61) - Drug Profile
Product Description
Mechanism Of Action
CRS-0540 - Drug Profile
Product Description
Mechanism Of Action
History of Events
Monoclol Antibodies for Streptococcus pyogenes Infections - Drug Profile
Product Description
Mechanism Of Action
RECCE-327 - Drug Profile
Product Description
Mechanism Of Action
History of Events
Small Molecule for Streptococcus Pyogenes Infections - Drug Profile
Product Description
Mechanism Of Action
Streptococcus [serotype A] vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
streptococcus pyogenes (30-valent) vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
Streptococcus pyogenes vaccine - Drug Profile
Product Description
Mechanism Of Action
Streptococcus pyogenes vaccine 1 - Drug Profile
Product Description
Mechanism Of Action
Streptococcus pyogenes vaccine 2 - Drug Profile
Product Description
Mechanism Of Action
Streptococcus pyogenes Infections - Dormant Projects
Streptococcus pyogenes Infections - Discontinued Products
Streptococcus pyogenes Infections - Product Development Milestones
Featured News & Press Releases
Jul 20, 2021: Recce Pharmaceuticals announces lead synthetic anti-infective RECCE 327 demonstrates outstanding efficacy against necrotizing fasciitis ?flesh-eating’ bacteria
Sep 05, 2019: Potential vaccine treats and prevents deadly streptococcal toxic shock
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Streptococcus pyogenes Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Streptococcus pyogenes Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Streptococcus pyogenes Infections - Pipeline by Cadila Healthcare Ltd, 2022
Streptococcus pyogenes Infections - Pipeline by Crestone Inc, 2022
Streptococcus pyogenes Infections - Pipeline by Olymvax Biopharmaceuticals Inc, 2022
Streptococcus pyogenes Infections - Pipeline by Recce Pharmaceuticals Ltd, 2022
Streptococcus pyogenes Infections - Pipeline by Wellstat Vaccines LLC, 2022
Streptococcus pyogenes Infections - Dormant Projects, 2022
Streptococcus pyogenes Infections - Discontinued Products, 2022